Besides the great importance of proinflammatory cytokines, such as IFN-β, in modulating myelin debris clearance, excessive inflammatory response is detrimental in MS development, therefore different therapeutic approaches aim to decrease the neuroinflammation in MS. The gene discussed is IFNB1; the disease is myeloid sarcoma.